| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGACGCGCCUCUGCAUCUGCGCCAGGCGAACGGGUCCUGCGCCUCCUGC… | 2032 nt | 0.4503 | |
| AAUGGUAUGACUUUUUUUCUGGAGUCCCCUCUUCUGAUUCUUGAACUCC… | 1877 nt | 0.4358 | |
| ACUUCUCCACCUGAAGGCUGGGCGUUGCUGGAACCUGCAGGGGCAGCCU… | 1823 nt | 0.4361 | |
| AGGCAGCGCUGUGCUCAGGGGCCAUUUUGAACAGUGAAACCACCAACAA… | 2161 nt | 0.4345 | |
| AGACGCGCCUCUGCAUCUGCGCCAGGCGAACGGGUCCUGCGCCUCCUGC… | 2035 nt | 0.4506 |
This gene encodes a preproprotein that is proteolytically processed to generate a secreted peptide that belongs to the endothelin/sarafotoxin family. This peptide is a potent vasoconstrictor and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of this gene may promote tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
A study in humans demonstrated that the EDN1 is a potent vasoconstrictor whose expression is upregulated in fibroblasts treated with the WNT pathway activator SKL2001, representing a pathological state [Zhao et al. DOI:10.1038/s41467-022-31950-9]. In a rat model of radiation-induced lung injury, the EDN1 was identified as an orthologous gene associated with inflammatory processes [Shi et al. DOI:10.17305/bb.2024.10357].